Imai, et al. identified that in mice treated with human amnion-derived MSCs (hAMSC), the gene expression levels of IL-17A, IL-22, and CXCL1 were significantly reduced in the mouse model of IMQ-induced psoriasis [137]. This evidence concerns the gene IL22 and psoriasis.